Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 618,116 | 681,728 | 558,000 | 603,765 | 535,150 |
| Cost of Goods | 283,636 | 289,524 | 270,000 | 286,045 | 246,697 |
| Gross Profit | 334,480 | 392,204 | 288,000 | 315,720 | 288,453 |
| Operating Expenses | 231,749 | 288,841 | 172,000 | 235,556 | 209,517 |
| Operating Income | 103,367 | 103,887 | 115,000 | 80,209 | 79,633 |
| Interest Expense | 2,143 | 4,317 | 4,000 | 3,867 | 7,159 |
| Other Income | -175,587 | 9,258 | 12,000 | 12,315 | 8,215 |
| Pre-tax Income | -74,363 | 108,829 | 123,000 | 88,657 | 80,690 |
| Income Tax | 5,964 | -46,306 | 27,000 | 22,143 | 13,247 |
| Net Income Continuous | -80,328 | 155,135 | 96,000 | 66,514 | 67,443 |
| Net Income | $-80,328 | $155,135 | $96,000 | $65,514 | $67,443 |
| EPS Basic Total Ops | -0.10 | 0.19 | 0.12 | 0.08 | 0.08 |
| EPS Basic Continuous Ops | -0.10 | 0.19 | 0.12 | 0.08 | 0.08 |
| EPS Diluted Total Ops | -0.10 | 0.19 | 0.12 | 0.08 | 0.08 |
| EPS Diluted Continuous Ops | -0.10 | 0.19 | 0.12 | 0.08 | 0.08 |
| EBITDA(a) | $145,367 | $149,887 | $161,000 | $127,209 | $128,633 |